Pharmacists now have access to a tremendous amount of data through electronic health records, surveillance systems, online resources and pharmacy programs. However, curating this data to ensure that critical information, particularly regarding adverse drug events, is appropriately retrieved and analyzed can feel overwhelming.
Ensuring that essential information is acted upon in a timely manner requires aligning alerts and reports with operational workflow. Predictive analytics should be incorporated as an important part of the technology and processes that support clinical pharmacy activities.
On January 20, join John Hertig, PharmD, MS, CPPS, associate director at the Purdue University College of Pharmacy Center for Medication Safety Advancement, in a webinar focused on addressing these issues in the clinical pharmacy. Dr. Hertig will share best practices for using data to improve care and drive quality improvement most effectively.
He will also explore how pharmacists can find the right sources of data and use them to improve the quality of care and drive sustainable improvements in patient health. Specifically, he will discuss how to identify and collect pertinent data, how to develop strategies for executing on the data collected, and how to implement several methods used to effectively and efficiently improve patient care and medication safety.
John B. Hertig, PharmD, MS, CPPS is the associate director of the Purdue University College of Pharmacy Center for Medication Safety Advancement (CMSA). He also has a courtesy appointment as clinical assistant professor of Pharmacy Practice at Purdue. Dr. Hertig received his Bachelors of Science in Pharmaceutical Sciences and Doctor of Pharmacy degrees from Purdue University. Following graduation he completed a combined PGY1/PGY2 Masters in Health-System Pharmacy Administration residency at The Ohio State University Medical Center in Columbus, Ohio. As part of this program, he received a Master’s degree in Health-System Pharmacy Administration from The Ohio State University.
In his current role, Dr. Hertig assists in setting and managing the mission and vision of CMSA, leads strategic initiatives, forms partnerships, educates, and acts as a catalyst to help improve the lives of the patients throughout Indiana and beyond. He serves as the program director for the Medication Safety Fellowship joint program, maintained in collaboration with Eli Lilly and the Food and Drug Administration. Dr. Hertig serves on a number of boards and as an advisor to both the FDA and CMS.
His experience and focus areas include: pharmacy practice models, leadership development, medication safety, quality outcomes, health policy, and performance improvement. He is committed to organizational involvement and serves in various local and national pharmacy leadership roles.